查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596059

神经血管栓塞装置的全球市场：到 2033 年的机会和策略

Neurovascular Embolization Devices Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 313 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2018年全球神经血管栓塞器械市值为10.6641亿美元，到2023年年复合成长率(CAGR)将超过3.0%。

提高对神经血管疾病的认识

对神经血管疾病的认识不断提高，推动了业绩期内神经血管栓塞器材市场的发展。人们对中风和动脉瘤等疾病的认识不断提高，导致诊断数量增加，对有效治疗方案的需求增加。随着认识宣传活动和教育活动强调早期疗育的重要性，对先进神经血管栓塞设备的需求迅速增加。这种认识的提高扩大了潜在的患者群体，并促进了用于诊断和管理神经血管疾病的设备的采用。例如，根据西雅图华盛顿大学健康指标与评估研究所 (IHME)主导的一项综合性倡议「全球疾病、伤害和风险因素负担研究」(GBD)，超过 34 亿人（更多超过40% 的世界人口）受到神经病变的影响。研究发现，37 种神经系统疾病导致全球 4.43 亿伤残调整生命年 (DALY) 和 1,110 万人死亡，其中约 80% 的影响发生在低收入和中等收入人群中。

目录

第一章执行摘要

  • 神经血管栓塞装置 - 市场吸引力和宏观经济条件

第二章 目录

第三章表格一览

第四章图表一览

第五章 报告结构

第六章市场特点

  • 一般市场定义
  • 概述
  • 神经血管栓塞设备市场定义与细分
  • 市场区隔：按产品
    • 栓塞弹簧圈
    • 液体栓塞系统
    • 血流导流支架
    • 动脉瘤夹
    • 其他产品
  • 市场区隔：依治疗方式
    • 缺血性中风解决方案
    • 出血性中风的解决方案
  • 市场区隔：依适应症分类
    • 脑动脉瘤
    • 动静脉畸形
    • 其他适应症
  • 市场区隔：按最终用户
    • 医院
    • 门诊手术中心
    • 其他最终用户

第七章 主要市场趋势

  • 推出创新薄型可视化腔内支撑装置
  • 一种用于治疗缺血性和出血性中风的新型神经血管装置
  • 复杂神经血管解剖的导管设计创新
  • 先进的栓塞系统增强微创手术

第八章神经血管栓塞器械市场-宏观经济情景

  • COVID-19 的影响：神经血管栓塞装置市场
  • 乌克兰战争的影响：神经血管栓塞器材市场
  • 高通膨的影响：神经血管栓塞器械市场

第九章世界市场规模与成长

  • 市场规模
  • 2018-2023 年市场成长表现
    • 市场驱动因素，2018-2023
    • 市场限制，2018-2023
  • 2023-2028 年、2033 年市场成长预测
    • 2023-2028 年市场驱动因素
    • 市场限制，2023-2028

第十章全球神经血管栓塞器械市场：细分

  • 全球神经血管栓塞器械市场：按产品、性能和预测，2018-2023、2028、2033
  • 全球神经血管栓塞设备市场：按治疗、性能和预测，2018-2023、2028、2033
  • 全球神经血管栓塞设备市场：最终用户的表现和预测，2018-2023、2028、2033
  • 全球神经血管栓塞器材市场：依适应症、表现及预测划分，2018-2023年、2028年、2033年

第十一章神经血管栓塞装置市场：区域与国家分析

  • 全球神经血管栓塞器材市场：2018-2023、2028、2033年各地区表现及预测
  • 全球神经血管栓塞装置市场：2018-2023年、2028年、2033年各国表现与预测

第十二章亚太市场

第十三章西欧市场

第十四章 东欧市场

第十五章 北美市场

第十六章 南美洲市场

第十七章 中东市场

第十八章 非洲市场

第十九章 竞争格局及公司概况

  • 公司简介
  • Terumo Corporation
  • Medtronic Inc
  • Penumbra Inc
  • Stryker Corporation
  • Johnson & Johnson

第二十章 其他大型创新企业

  • Cook Medical LLC
  • Abbott Laboratories
  • MicroPort
  • Asahi Intecc Co Ltd
  • Boston Scientific Corporation
  • Merit Medical Systems, Inc
  • InNeuroCo Inc
  • B. Braun Melsungen AG
  • BALT Group
  • Acandis GmbH
  • Wallaby Medical（Phenox GmbH）
  • Heraeus
  • Integra LifeSciences Corporation
  • Shape Memory Medical
  • NeuroVasc Technologies, Inc

第二十一章 重大併购

  • Stryker Corporation Acquired Cerus Endovascular Ltd
  • Boston Scientific Corporation Acquired Obsidio, Inc
  • Wallaby Medical Acquired Phenox GmbH

第22章机会与策略

  • 2028 年全球神经血管栓塞器材市场：提供新机会的国家
  • 2028 年全球神经血管栓塞器材市场：提供新机会的细分市场
  • 2028 年全球神经血管栓塞器材市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第23章神经血管栓塞装置市场：结论与建议

  • 结论
  • 推荐
    • 产品
    • 地方
    • 价格
    • 晋升
    • 人们

第24章附录

简介目录
Product Code: o&s1370

neurovascular conditions, particularly those involving abnormal blood flow in the brain. These devices are designed to prevent or reduce blood flow to problematic areas, such as aneurysms, arteriovenous malformations (AVMs) or other vascular abnormalities in the brain. By effectively stopping blood flow to these targeted areas, neurovascular embolization devices help to prevent hemorrhages, reduce bleeding risks and stabilize or resolve potentially life-threatening vascular abnormalities.

The neurovascular embolization devices market consists of sales, by entities (organizations, sole traders and partnerships), of neurovascular embolization devices that are used to treat conditions affecting the blood vessels in the brain.

The global neurovascular embolization devices market was valued at $1,066.41 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 3.0%.

Increasing Awareness Of Neurovascular Disorders

During the historic period, the increasing awareness of neurovascular disorders has driven the neurovascular embolization devices market. The growing recognition of conditions such as stroke and aneurysms led to more diagnoses and a higher demand for effective treatment options. As awareness campaigns and educational initiatives emphasized the importance of early intervention, the need for advanced neurovascular embolization devices surged. This heightened awareness expanded the potential patient population and drove up the adoption of devices designed for the diagnosis and management of neurovascular conditions. For example, in 2021, according to the Global Burden of Diseases, Injuries and Risk Factors Study (GBD), a comprehensive initiative led by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, Seattle, over 3.4 billion people-more than 40% of the global population-were affected by neurological disorders. The study highlighted that 37 neurological conditions were responsible for 443 million disability-adjusted life-years (DALYs) and 11.1 million deaths globally, with around 80% of these impacts occurring in low- and middle-income countries.

Launch Of Innovative Low-Profile Visualized Intraluminal Support Devices

Major companies operating in the neurovascular embolization devices market are focusing on launching innovative low-profile visualized intraluminal support devices that deliver enhanced imaging clarity during procedures, enabling accurate placement and precise control over deployment. For instance, in June 2024, MicroVention Inc, a US-based company that provides neurovascular embolization devices, announced the launch of its LVIS(TM) EVO(TM) (Low-Profile Visualized Intraluminal Support) Intraluminal Support Device, specifically designed for the treatment of wide-neck intracranial aneurysms in patients aged 18 and above. This stent is distinguished as the first fully visible coil-assist intracranial stent available in the US market, offering enhanced visibility under fluoroscopy, which facilitates accurate placement and controlled deployment. The LVIS(TM) EVO(TM) incorporates advanced design features, including Drawn Filled Tube (DFT) wire construction and an optimized braid angle, enabling improved opening and the capacity to resheath up to 80% of its length.

The global neurovascular embolization devices market is concentrated, with a few large players operating in the market. The top ten competitors in the market made up to 40.6% of the total market in 2023.

Neurovascular Embolization Devices Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global neurovascular embolization devices market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for neurovascular embolization devices? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The neurovascular embolization devices market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider neurovascular embolization devices market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by treatment, by indication and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the neurovascular embolization devices market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by treatment, by indication and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for neurovascular embolization devices providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Embolization Coils; Liquid Embolic Systems; Flow Diversion Stents; Aneurysm Clips; Other Products
  • 2) By Treatment: Ischemic Stroke Solution; Hemorrhagic Stroke Solutions
  • 3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End Users
  • 4) By Indication: Brain Aneurysms; Arteriovenous Malformation; Other Indications
  • Companies Mentioned: Terumo Corporation;Medtronic Plc;Penumbra Inc; Stryker Corporation;Johnson & Johnson
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; neurovascular embolization devices indicators comparison
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Neurovascular Embolization Devices - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Neurovascular Embolization Devices Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Embolization Coils
    • 6.4.2 Liquid Embolic Systems
    • 6.4.3 Flow Diversion Stents
    • 6.4.4 Aneurysm Clips
    • 6.4.5 Other Products
  • 6.5 Market Segmentation By Treatment
    • 6.5.1 Ischemic Stroke Solutions
    • 6.5.2 Hemorrhagic Stroke Solutions
  • 6.6 Market Segmentation By Indication
    • 6.6.1 Brain Aneurysms
    • 6.6.2 Arteriovenous Malformation
    • 6.6.3 Other Indications
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Hospitals
    • 6.7.2 Ambulatory Surgical Centers
    • 6.7.3 Other End-Users

7 Major Market Trends

  • 7.1 Launch Of Innovative Low-Profile Visualized Intraluminal Support Devices
  • 7.2 New Neurovascular Devices For Ischemic And Hemorrhagic Stroke Management
  • 7.3 Innovations In Catheter Design For Complex Neurovascular Anatomy
  • 7.4 Advanced Embolic System Enhances Minimally Invasive Procedures

8 Neurovascular Embolization Devices Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The Neurovascular Embolization Devices Market
  • 8.2 Impact Of The War In Ukraine On The Neurovascular Embolization Devices Market
  • 8.3 Impact Of High Inflation On The Neurovascular Embolization Devices Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Neurovascular Embolization Devices Market Segmentation

  • 10.1 Global Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Neurovascular Embolization Devices Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Neurovascular Embolization Devices Market, Regional and Country Analysis

  • 11.1 Global Neurovascular Embolization Devices Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Neurovascular Embolization Devices Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia Pacific Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia Pacific Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia Pacific Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Neurovascular Embolization Devices Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Regulations
    • 12.9.6 Regulatory Bodies
    • 12.9.7 Major Associations
    • 12.9.8 Taxes Levied
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Investments
    • 12.9.11 Major Companies
  • 12.10 China Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Neurovascular Embolization Devices Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 France Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Spain Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Neurovascular Embolization Devices Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Neurovascular Embolization Devices Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.10 USA Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 South America Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Neurovascular Embolization Devices Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Middle East Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Investments
    • 18.2.11 Major Companies
  • 18.3 Africa Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Terumo Corporation
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Medtronic Inc
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Penumbra Inc
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Stryker Corporation
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Johnson & Johnson
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 Cook Medical LLC
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
  • 20.2 Abbott Laboratories
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
  • 20.3 MicroPort
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
  • 20.4 Asahi Intecc Co Ltd
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Boston Scientific Corporation
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
  • 20.6 Merit Medical Systems, Inc
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
  • 20.7 InNeuroCo Inc
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
  • 20.8 B. Braun Melsungen AG
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
  • 20.9 BALT Group
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
  • 20.10 Acandis GmbH
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
  • 20.11 Wallaby Medical (Phenox GmbH)
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Heraeus
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 Integra LifeSciences Corporation
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
  • 20.14 Shape Memory Medical
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
  • 20.15 NeuroVasc Technologies, Inc
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Key Mergers And Acquisitions

  • 21.1 Stryker Corporation Acquired Cerus Endovascular Ltd
  • 21.2 Boston Scientific Corporation Acquired Obsidio, Inc
  • 21.3 Wallaby Medical Acquired Phenox GmbH

22 Opportunities And Strategies

  • 22.1 Global Neurovascular Embolization Devices Market In 2028 - Countries Offering Most New Opportunities
  • 22.2 Global Neurovascular Embolization Devices Market In 2028 - Segments Offering Most New Opportunities
  • 22.3 Global Neurovascular Embolization Devices Market In 2028 - Growth Strategies
    • 22.3.1 Market Trend Based Strategies
    • 22.3.2 Competitor Strategies

23 Neurovascular Embolization Devices Market, Conclusions And Recommendations

  • 23.1 Conclusions
  • 23.2 Recommendations
    • 23.2.1 Product
    • 23.2.2 Place
    • 23.2.3 Price
    • 23.2.4 Promotion
    • 23.2.5 People

24 Appendix

  • 24.1 Geographies Covered
  • 24.2 Market Data Sources
  • 24.3 Research Methodology
  • 24.4 Currencies
  • 24.5 The Business Research Company
  • 24.6 Copyright and Disclaimer